# Verastem, Inc. (NASDAQ: VSTM), Needham, MA – FDA Inspections

Source: https://www.keypedia.com/companies/verastem-inc/d477d311-6bcc-4a68-ba12-e2255081e340

> Inspection records and compliance data for Verastem, Inc. in Needham, Massachusetts. 2 FDA inspections on record, 1 Form 483, last inspected February 05, 2025. Publicly traded as NASDAQ: VSTM.

---

## Details

- Name: Verastem, Inc.
- FEI Number: 3011454257
- Address Line 1: 117 Kendrick St Ste 500
- City: Needham
- State: Massachusetts
- Zip Code: 02494
- Country Name: United States
- Address: 117 Kendrick St Ste 500, Needham, Massachusetts 02494, United States
- Country: United States

## Stock

- Stock ticker: VSTM
- Exchange: NASDAQ
- Share price: $8.44
- Market cap: $1.1B
- Price as of: November 13, 2026

## Related Documents

- [483 - Verastem, Inc. - 2025-02-05](https://www.keypedia.com/records/483/verastem-inc/1665fdda-f2c2-4191-9712-28da855e25d6) — source: FDA, date: February 5, 2025
- [FDA Inspection 1260096 - Verastem, Inc. - 2025-02-05](https://www.keypedia.com/records/fda_inspections/verastem-inc/9d7e3254-fcb3-47a1-bfc5-38672ace735e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 5, 2025
- FDA Inspection 1260096 - Verastem, Inc. - 2025-02-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 5, 2025
- FDA Inspection 1053659 - Verastem, Inc. - 2018-05-10 — classification: No Action Indicated (NAI), source: FDA, date: May 10, 2018

## Related Companies

- [Karyopharm Therapeutics Inc.](https://www.keypedia.com/companies/karyopharm-therapeutics-inc/28ffa225-b02c-40a0-8662-5bed25336a5a)
- [Aveo Pharmaceuticals Inc.](https://www.keypedia.com/companies/aveo-pharmaceuticals-inc/a2eaa018-1540-42fe-9d11-7e0e3b465daa)
- [Alnylam Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/918c30c3-22a5-436f-88c1-6af91b2c575a)
- [Partner Therapeutics, Inc.](https://www.keypedia.com/companies/partner-therapeutics-inc/02b6f3e3-ef3e-4352-9f94-1e462de5f2b4)
- [Servier Pharmaceuticals, LLC.](https://www.keypedia.com/companies/servier-pharmaceuticals-llc/d72f7c9b-a32a-4c7c-97aa-89001e1341aa)
- [Citius Pharmaceuticals, Inc.](https://www.keypedia.com/companies/citius-pharmaceuticals-inc/1aa4934c-96a3-4ecb-a923-8ecd4e362d62)
- [Exemplar Pharmaceuticals LLC](https://www.keypedia.com/companies/exemplar-pharmaceuticals-llc/151a6f00-549b-403b-b79f-3d979f6246b5)
- [Blueprint Medicines Corporation](https://www.keypedia.com/companies/blueprint-medicines-corporation/92f765e6-81ff-46de-8cb1-dee7e91213fa)
- [Alexion Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015)
- [R. Doyle Stulting, MD](https://www.keypedia.com/companies/r-doyle-stulting-md/d714b48d-d12b-4a51-ab57-ed8f21f8e50d)

## Related Officers

- [Meredith L. Miller](https://www.keypedia.com/people/meredith-l-miller/c775003b-4e5b-48d8-bc51-1a3ebe813dba)
